Juan Moróte

7.4k total citations
358 papers, 4.8k citations indexed

About

Juan Moróte is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Juan Moróte has authored 358 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Pulmonary and Respiratory Medicine, 90 papers in Surgery and 64 papers in Molecular Biology. Recurrent topics in Juan Moróte's work include Prostate Cancer Treatment and Research (183 papers), Prostate Cancer Diagnosis and Treatment (133 papers) and Bladder and Urothelial Cancer Treatments (52 papers). Juan Moróte is often cited by papers focused on Prostate Cancer Treatment and Research (183 papers), Prostate Cancer Diagnosis and Treatment (133 papers) and Bladder and Urothelial Cancer Treatments (52 papers). Juan Moróte collaborates with scholars based in Spain, Palestinian Territory and United States. Juan Moróte's co-authors include Jacques Planas, Enrique Trilla, Carles X. Raventós, Jaume Reventós, G Encabo, Lluís Cecchini, Anna Orsola, Inés M. de Torres, J.M. Abascal Junquera and A. Celma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Juan Moróte

339 papers receiving 4.6k citations

Peers

Countries citing papers authored by Juan Moróte

Since Specialization

Citations

This map shows the geographic impact of Juan Moróte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Moróte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Moróte more than expected).

Fields of papers citing papers by Juan Moróte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Moróte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Moróte. The network helps show where Juan Moróte may publish in the future.

Co-authorship network of co-authors of Juan Moróte

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Moróte. A scholar is included among the top collaborators of Juan Moróte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Moróte. Juan Moróte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired–Matched Study 2025 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), (unknown), A. Celma, (unknown), Berta Miró, (unknown), J.M. Abascal Junquera, (unknown), Juan Moróte	0
2	Analysis of Inflammatory Features in Suspicious Lesions for Significant Prostate Cancer on Magnetic Resonance Imaging—Are They Mimickers of Prostate Cancer? 2024 ·Cancers ·Juan Moróte, A. Celma, (unknown), (unknown), Berta Miró, Olga Méndez, Enrique Trilla	0
3	Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures, and serum samples from a Spanish Caucasian population 2024 ·Frontiers in Oncology ·(unknown), (unknown), Javier Garcı́a Garcı́a, (unknown), A. Celma, Juan Moróte, Inés de Torres, (unknown), Roser Ferrer, Rosanna Paciucci	2
4	Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with transperineal prostate biopsies 2024 ·International braz j urol ·Juan Moróte, (unknown), (unknown), (unknown), (unknown), (unknown), A. Celma, (unknown), Berta Miró, (unknown), J.M. Abascal Junquera	2
5	Sequencing the Barcelona‐MRI predictive model and Proclarix for improving the uncertain PI‐RADS 3 2024 ·SHILAP Revista de lepidopterología ·Juan Moróte, A. Celma, Olga Méndez, Enrique Trilla	0
6	The effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies 2024 ·International braz j urol ·(unknown), Violeta Catalá, (unknown), Xavier Alomar, (unknown), (unknown), Juan Moróte	3
7	The Role of Radiomics in the Prediction of Clinically Significant Prostate Cancer in the PI-RADS v2 and v2.1 Era: A Systematic Review 2024 ·Cancers ·(unknown), Núria Rosón, Richard Mast, Javier Pizones, (unknown), (unknown), (unknown), Manuel Escobar, Enrique Trilla, Juan Moróte	5
8	The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate Volume 2023 ·The World Journal of Men s Health ·Juan Moróte, (unknown), (unknown), (unknown), (unknown), (unknown), A. Celma, (unknown), Berta Miró, J.M. Abascal Junquera, (unknown)	5
9	Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review 2022 ·Cancers ·(unknown), (unknown), A. Celma, Lucas Regis, (unknown), Jacques Planas, Enrique Trilla, Juan Moróte	16
10	Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging? 2022 ·The International Journal of Biological Markers ·Juan Moróte, (unknown), Lucas Regis, A. Celma, Inés de Torres, (unknown), S. Roche, Richard Mast, Anna Santamaría, Jacques Planas, Enrique Trilla	3
11	Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy 2022 ·Cancers ·(unknown), Lucas Regis, Mathias Winkler, Nicolás Valdés Ortega, (unknown), A. Celma, Jacques Planas, Juan Moróte, Enrique Trilla	7
12	Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate‐specific antigen, digital rectal examination and the prostate‐specific antigen density based on digital rectal prostate volume category 2022 ·SHILAP Revista de lepidopterología ·Juan Moróte, (unknown), (unknown), J.M. Abascal Junquera, (unknown), Enrique Trilla	4
13	Definition of Castrate Resistant Prostate Cancer: New Insights 2022 ·Biomedicines ·Juan Moróte, Adriana Aguilar, Jacques Planas, Enrique Trilla	31
14	Are Multiparametric Magnetic Resonance Imaging and Guided Biopsies Needed in Men with Normal Digital Rectal Examination and Prostatic-specific Antigen >20 ng/ml? 2021 ·European Urology Oncology ·Juan Moróte, A. Celma, Jacques Planas	1
15	Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples 2021 ·Cancers ·Mireia Oliván, Marta García, (unknown), Marc Guiu, (unknown), Olga Méndez, Marina Rigau, Jaume Reventós, Miguel F. Segura, Inés de Torres, Jacques Planas, Xavier de la Cruz, Roger R. Gomis, Juan Moróte, Ruth Rodríguez‐Barrueco, Anna Santamaría	11
16	A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells 2019 ·Cancer Letters ·(unknown), (unknown), (unknown), Valentí Gómez, Inés de Torres, (unknown), Juan Moróte, Verónique Noé, Carlos J. Ciudad, Rosanna Paciucci	4
17	How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies 2019 ·World Journal of Urology ·Ángel Borque‐Fernando, Luis Esteban, A. Celma, S. Roche, Jacques Planas, Lucas Regis, Inés de Torres, (unknown), Enrique Trilla, Juan Moróte	8
18	Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival 2017 ·Oncotarget ·Jordi Vilardell, (unknown), Eduard Sarró, (unknown), Thaïs Cuadros, Inés de Torres, Maria Plana, Santiago Ramón y Cajal, Lorenzo A. Pinna, Maria Ruzzene, Juan Moróte, Anna Meseguer, Emilio Itarte	15
19	HAVCR/KIM-1 Activates the IL-6/STAT-3 Pathway in Clear Cell Renal Cell Carcinoma and Determines Tumor Progression and Patient Outcome 2014 ·Cancer Research ·Thaïs Cuadros, (unknown), Eduard Sarró, Maya R. Vilà, Jordi Vilardell, Inés de Torres, (unknown), Joan López-Hellín, Álex Sánchez‐Pla, Santiago Ramón y Cajal, Emilio Itarte, Juan Moróte, Anna Meseguer	76
20	The Present and Future of Prostate Cancer Urine Biomarkers 2013 ·International Journal of Molecular Sciences ·Marina Rigau, Mireia Oliván, Marta García, Tamara Sequeiros, Melania Montes, Eva Colás, (unknown), Jacques Planas, Inés de Torres, Juan Moróte, Colin Cooper, Jaume Reventós, Jeremy Clark, Andreas Doll	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact